7.85
price up icon29.86%   1.805
 
loading

Synaptogenix Inc 주식(SNPX)의 최신 뉴스

pulisher
Jun 17, 2025

Small-cap healthcare stocks with explosive potential - businessnewsthisweek.com

Jun 17, 2025
pulisher
Jun 13, 2025

bioAffinity Technologies Stock Price, Quotes and Forecasts | NASDAQ:BIAF - Benzinga

Jun 13, 2025
pulisher
Jun 12, 2025

Pre-market Movers: HCTI, KLTO, INTS, HSDT... - RTTNews

Jun 12, 2025
pulisher
Jun 11, 2025

This cryptocurrency breaks into the elite of digital assets used as reserves in corporate treasuries. - Bit2Me News

Jun 11, 2025
pulisher
Jun 10, 2025

TAO Is Next for Corporate Treasury, Nasdaq Giants Fuel Bittensor’s 10% Rally - Coinspeaker

Jun 10, 2025
pulisher
Jun 10, 2025

Bittensor (TAO) Becomes the Next Pick in the Wave of Public Crypto Treasuries - BeInCrypto

Jun 10, 2025
pulisher
Jun 10, 2025

Health Care Sector Sees Mixed Results And Strategic Moves - Finimize

Jun 10, 2025
pulisher
Jun 09, 2025

Synaptogenix pumps $100m into artificial intelligence token - Mugglehead Magazine

Jun 09, 2025
pulisher
Jun 09, 2025

Klotho Neurosciences Sees Massive Jump After Promising Gene Study - Finimize

Jun 09, 2025
pulisher
Jun 09, 2025

Synaptogenix (SNPX) Unveils AI-Focused Cryptocurrency Strategy | SNPX Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Synaptogenix, Inc. announced that it expects to receive $5.5 million in funding - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Synaptogenix Unveils TAO-Focused Crypto Treasury Plan - Live Bitcoin News

Jun 09, 2025
pulisher
Jun 09, 2025

Synaptogenix Appoints James Altucher to Lead Digital Asset Treasury Strategy - citybiz

Jun 09, 2025
pulisher
Jun 09, 2025

Synaptogenix Says On June 8, Alan Tuchman Resigned As CEO And Director Of Co - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Synaptogenix Launch Of Differentiated Cryptocurrency Treasury Strategy Focused Exclusively On AI Crypto Token 'TAO' - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

Synaptogenix Stock Soars on Bold AI Crypto Bet - RagingBull

Jun 09, 2025
pulisher
Jun 09, 2025

Synaptogenix Announces $5.5M Securities Purchase Agreement - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

Synaptogenix Appoints Crypto Expert to Lead Digital Asset Treasu - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Synaptogenix Appoints Crypto Expert to Lead Digital Asset Treasury Strategy Focused Exclusively on Top-Valued AI Token | SNPX Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

First Pure-Play AI Crypto Stock: Synaptogenix Commits $100M to Leading AI Token TAO, Appoints Crypto Expert - Stock Titan

Jun 09, 2025
pulisher
Jun 05, 2025

Full Stock Market News from 2025-06-06 - Stock Titan

Jun 05, 2025
pulisher
Jun 05, 2025

Synaptogenix, Inc. (NASDAQ:SNPX) Short Interest Update - Defense World

Jun 05, 2025
pulisher
May 28, 2025

Synaptogenix (NASDAQ:SNPX) Trading 1.5% Higher – Here’s What Happened - Defense World

May 28, 2025
pulisher
May 27, 2025

Full Stock Market News from 2025-05-27 - Stock Titan

May 27, 2025
pulisher
May 22, 2025

Full Stock Market News from 2025-05-22 - Stock Titan

May 22, 2025
pulisher
May 06, 2025

SNPXSynaptogenix Latest Stock News & Market Updates - Stock Titan

May 06, 2025
pulisher
May 06, 2025

Geode Capital Management LLC Takes $39,000 Position in Synaptogenix, Inc. (NASDAQ:SNPX) - Defense World

May 06, 2025
pulisher
Apr 05, 2025

Synaptogenix stock plunges to 52-week low of $2.14 By Investing.com - Investing.com Canada

Apr 05, 2025
pulisher
Apr 04, 2025

Synaptogenix stock plunges to 52-week low of $2.14 - Investing.com Australia

Apr 04, 2025
pulisher
Mar 27, 2025

Synaptogenix Inc. (SNPX) reports earnings - qz.com

Mar 27, 2025
pulisher
Mar 25, 2025

Will Synaptogenix Make A Mark In Synaptic Regeneration? - RTTNews

Mar 25, 2025
pulisher
Mar 20, 2025

Synaptogenix stock hits 52-week low at $2.15 amid market challenges - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

Synaptogenix stock hits 52-week low at $2.15 amid market challenges By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 14, 2025

Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC - Benzinga

Mar 14, 2025
pulisher
Mar 13, 2025

Synaptogenix (NASDAQ:SNPX) Trading Down 0.3% – Here’s Why - Defense World

Mar 13, 2025
pulisher
Mar 07, 2025

Sonnet BioTherapeutics Stock Price, Quotes and Forecasts - Benzinga

Mar 07, 2025
pulisher
Mar 06, 2025

Mustang Bio Stock Price, Quotes and Forecasts | NASDAQ:MBIO - Benzinga

Mar 06, 2025
pulisher
Mar 06, 2025

Aptevo Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:APVO - Benzinga

Mar 06, 2025
pulisher
Feb 07, 2025

ZyVersa Therapeutics (NASDAQ:ZVSA) Stock Quotes, Forecast and News Summary - Benzinga

Feb 07, 2025
pulisher
Jan 20, 2025

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.18% - MSN

Jan 20, 2025
pulisher
Jan 02, 2025

Finance Watch: As Cash Dwindles, Biotechs Cut Costs, Sell Assets, Merge, Assess Options - News & Insights

Jan 02, 2025
pulisher
Dec 23, 2024

Synaptogenix Forms Special Committee to Explore Value Creation Opportunities Utilizing Balance Sheet Strength - Marketscreener.com

Dec 23, 2024
pulisher
Dec 22, 2024

Synaptogenix (SNPX) Extends CEO’s Employment and Forms Special Committee to Explore Strategic Opportunities - Defense World

Dec 22, 2024
pulisher
Dec 20, 2024

Synaptogenix Forms Special Committee to Explore Strategic Options with $19.6M Cash Runway - StockTitan

Dec 20, 2024
pulisher
Dec 09, 2024

Informatica Leads Gartner Magic Quadrant for Data Integration Tools for 19th Straight Year - Stock Titan

Dec 09, 2024
pulisher
Oct 04, 2024

Synaptogenix appoints new auditor as Morison Cogen exits - Investing.com

Oct 04, 2024
pulisher
Sep 11, 2024

Synaptogenix Announces $5.0 Million Financing - citybiz

Sep 11, 2024
pulisher
Jul 06, 2024

Polyrizon Stock Price, Quotes and Forecasts | NASDAQ:PLRZ - Benzinga

Jul 06, 2024
pulisher
Jul 03, 2024

Synaptogenix cleared to launch Phase 1 trial of bryostatin-1 in MS - Multiple Sclerosis News Today

Jul 03, 2024
pulisher
Jun 27, 2024

FDA grants IND authorisation for Synaptogenix’s multiple sclerosis trial - Clinical Trials Arena

Jun 27, 2024
$20.74
price up icon 0.27%
$35.88
price down icon 0.50%
$21.20
price down icon 0.45%
$97.62
price down icon 2.98%
$107.48
price up icon 0.95%
biotechnology ONC
$245.16
price up icon 1.13%
자본화:     |  볼륨(24시간):